Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B95b08b0e7b6dd8e2bb410d70ee6ac0d6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B95b08b0e7b6dd8e2bb410d70ee6ac0d6 NCIT_P378 "NCI" @default.
- B95b08b0e7b6dd8e2bb410d70ee6ac0d6 type Axiom @default.
- B95b08b0e7b6dd8e2bb410d70ee6ac0d6 annotatedProperty IAO_0000115 @default.
- B95b08b0e7b6dd8e2bb410d70ee6ac0d6 annotatedSource NCIT_C71527 @default.
- B95b08b0e7b6dd8e2bb410d70ee6ac0d6 annotatedTarget "A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Anti-IGF-1R fully human monoclonal antibody SCH 717454 binds to membrane-bound IGF-1R, preventing binding of the ligand IGF-1 and the subsequent triggering of the PI3K/Akt signaling pathway; downregulation of this survival pathway may result in the induction of apoptosis and decreased cellular proliferation. The activation of IGF-1R, a tyrosine kinase and a member of the insulin receptor family, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been highly implicated in tumorigenesis and metastasis." @default.